Planned Parenthood wins partial victory in legal fight with Trump administration over funding cuts
A provision in that bill ends Medicaid payments for one year to abortion providers that received more than $800,000 from Medicaid in 2023, even to those like Planned Parenthood that also offer things like contraception, pregnancy tests and STD testing.
But U.S. District Judge Indira Talwani in Boston granted a preliminary injunction Monday that, for now, blocks the government from cutting Medicaid payments to Planned Parenthood member organizations that either don't provide abortion care or didn't meet a threshold of at least $800,000 in Medicaid reimbursements in a given year.
It wasn't immediately clear how many Planned Parenthood organizations and clinics would continue to get Medicaid reimbursements under that decision and how many might not.
Planned Parenthood said in a statement after the injunction that it's thankful the court recognized 'the harm' caused by the bill. But it said it's disappointed that some of its members will lose this funding, 'risking chaos, confusion, and harm for patients who could now be turned away when seeking lifesaving reproductive health care.'
'The court has not yet ruled on whether it will grant preliminary injunctive relief to other members,' the statement added. "We remain hopeful that the court will grant this relief. There will be nothing short of a public health crisis if Planned Parenthood members are allowed to be 'defunded.''
The lawsuit was filed earlier this month against Health and Human Services Secretary Robert F. Kennedy Jr. by Planned Parenthood Federation of America and its member organizations in Massachusetts and Utah.
Planned Parenthood argued that allowing the provision to take effect would have devastating consequences nationwide, including increased rates of undiagnosed and untreated sexually transmitted diseases and cancer.
'With no reason other than plain animus, the law will prevent Planned Parenthood Members from providing vital — indeed, lifesaving — care to more than one million patients,' they wrote. 'This statute is unconstitutional and will inflict irreparable harm on Planned Parenthood Members and their patients."
Lawyers for the government argued in court documents that the bill 'stops federal subsidies for Big Abortion.'
'All three democratically elected components of the Federal Government collaborated to enact that provision consistent with their electoral mandates from the American people as to how they want their hard-earned taxpayer dollars spent,' the government wrote in its opposition to the motion.
The government added that the plaintiffs 'now want this Court to reject that judgment and supplant duly enacted legislation with their own policy preferences. ... That request is legally groundless.'
Hours after the lawsuit was filed, Talwani issued a temporary restraining order that prevented the government from enforcing the cuts. That order had been set to expire Monday.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
19 minutes ago
- Boston Globe
Vatican strikes a solar deal that aims to make it the world's first carbon-neutral state
Over the years as the area became more developed, residents began complaining of health problems, including instances of childhood leukemia which they blamed on the electromagnetic waves generated by the towers. The Vatican denied there was any causal link but cut back the transmissions. Advertisement Pope Francis last year tasked the Vatican to study developing the area into a vast solar farm, hoping to put into practice his preaching about the need to transition away from fossil fuels and find clean, carbon-neutral energy sources. Pope Leo XIV visited the site in June and affirmed that he intended to see Francis' vision through. Leo has strongly taken up Francis' ecological mantle, recently using a new set of prayers and readings inspired by Pope Francis' environmental legacy. Advertisement The agreement signed Thursday stipulates that the development of the site will preserve the agricultural use of the land and minimize the environmental impact on the territory, according to a Vatican statement. Vatican officials have estimated it will cost under 100 million euros to develop the solar farm, and that once approved by Italy, the contracts to do the work can be put up for bids. In the 1990s at the height of the controversy, residents sued Vatican Radio officials, claiming the emissions exceeded the Italian legal limit, but the court cleared the transmitter. In 2012, the Vatican announced it was cutting in half the hours of transmission from the site, not because of health concerns but because of cost-saving technological advances in internet broadcasting. Associated Press religion coverage receives support through the AP's collaboration with The Conversation US, with funding from Lilly Endowment Inc. The AP is solely responsible for this content.
New York Post
19 minutes ago
- New York Post
West Virginia scrambles to strip artificial dyes from school meals before students return
When school starts in West Virginia next month, 240,000 students in districts large and small will notice something missing from their cafeteria trays. Gone will be red Jell-O fruit cups, yogurt topped with brightly hued sprinkles, and Cool Ranch Doritos — all foods made with synthetic dyes. In their place will be foods that contain colors made only from natural sources — such as vegetables, spices, and seeds — after West Virginia Gov. Patrick Morrisey signed a sweeping new law in March banning seven artificial dyes from school meals. 5 When school starts in West Virginia next month, 240,000 students in districts large and small will notice something missing from their cafeteria trays. AP Other states have enacted similar laws that would strip artificial dyes from school meals, but West Virginia's action is the first to take effect, starting Aug. 1. It triggered a four-month sprint that left state and local nutrition directors reeling. 'I think the initial reaction was like, 'Wow, what are we going to do?'' said Tony Crago, director of child nutrition for the West Virginia Department of Education. 'Where do we start?' Across the state, managers of school food programs scoured district grocery lists for dozens of products that contained any trace of petroleum-based synthetic dyes, including Red 3, Red 40, Yellow 5, Yellow 6, Blue 1, Blue 2, and Green 3. 'When it went into law, it was shocking,' said Diane Miller, who leads child nutrition and food services for Kanawha County Schools in the state's central region. 'We began to realize that these dyes were in much more than just your cereals.' West Virginia's ban on synthetic dyes was cheered by Health Secretary Robert F. Kennedy Jr., who has successfully pressured food makers to agree to remove artificial colors from their products. 5 West Virginia Gov. Patrick Morrisey signed a sweeping new law in March banning seven artificial dyes from school meals. AP The law focuses first on dyes in school foods, followed by a second action that will ban the colors plus two preservatives from all foods sold in the state starting in 2028. The move is aimed at halting potential health effects from the dyes, which have been linked to neurobehavioral problems, such as hyperactivity and attention problems, in some children. It's part of a larger focus on limiting artificial ingredients in food, Morrisey said in March. 5 Instead of jello and chips, foods in their place will contain colors made only from natural sources — such as vegetables, spices, and seeds Ezume Images – 'By eliminating harmful chemicals from our food, we're taking steps toward improving the health of our residents and protecting our children from significant long-term health and learning challenges,' he said. Health advocates have long called for the removal of the dyes, citing mixed evidence of potential harm. The U.S. Food and Drug Administration has said the color additives are safe when 'used properly,' in the amounts and products approved by the agency. Most children have no problems when consuming the dyes, the agency adds, 'but some evidence suggests that certain children may be sensitive to them.' More recently, however, FDA Commissioner Marty Makary has joined Kennedy in the push to get artificial dyes out of food, despite limited proof of health effects. 'When you get rid of petroleum-based dyes, kids aren't gonna all suddenly be healthy,' Makary said on a recent podcast. 'We're not going to address the fact that 30% of our nation's kids have prediabetes by simply removing petroleum-based food dyes. But these are steps in the right direction.' Nutrition experts agree that removing artificial colors from foods doesn't address the main drivers of America's chronic health problems. Those stem largely from ingredients such as added sugars, sodium, and saturated fat. But dyes are 'hallmarks of ultraprocessed food,' said Jerold Mande, a Harvard University nutrition expert and former federal food policy adviser. Targeting them could be a way of letting companies know 'that the way they're making food is unacceptable,' he said. Some suppliers had already removed artificial dyes from some school foods, swapping them for products colored with beet juice or turmeric, said Hollie Best, food service director for Wood County Schools in Parkersburg, which has 11,000 children in 27 schools. Overall, Best said she removed just five foods from her menus. General Mills said 98% of its products for schools were already made without the banned colors. The company 'will be compliant' with West Virginia's law immediately and plans to remove the dyes from school foods nationwide by next summer, said Mollie Wulff, a company spokesperson. In Miller's district, with 23,000 students in 67 schools, the new law affects about 10% of the foods served, she estimated. She expected some foods to contain artificial colors, like strawberry milk and Pop-Tarts. Others were surprising, such as pickles, salad dressing and certain snack chips. 'People were like, 'Oh my gosh, no more Doritos?'' Miller said. The popular Cool Ranch flavor contains dyes Red 40, Blue 1 and Yellow 5. The challenge is finding substitutes that will still appeal to children, Miller said. 'Because the last thing we need them to do is to choose not to participate in our school lunch program,' she said, adding that schools provide many students their healthiest meals of the day. Parents of children with sensitivities or allergies to artificial dyes had already raised concerns, according to school food directors. But for others, the presence of synthetic colors in school meals hasn't been an issue. Chris DeRico, nutrition director of Barbour County Schools, with 2,000 students, said few parents seemed worried about dyes. 5 West Virginia's ban on synthetic dyes was cheered by Health Secretary Robert F. Kennedy Jr., who has pressured food makers to agree to remove artificial colors from their products, according to reports. AP 5 West Virginia's action will take effect, starting Aug. 1, reports say. Monkey Business – 'They'd be in the minority, I believe,' he said. 'In rural West Virginia, I don't think it's really on radar screens.' In Best's district, dyes were already out of the food dished up during the summer session in July. That didn't make much difference to Lilith Wilson, 9, who said her meal of a meatball sub sandwich, sweet potato fries and ice cream was 'really good.' Asked whether she likes school lunches in general, the incoming fourth-grader echoed the sentiments of picky kids everywhere: 'Sometimes I don't, sometimes I do. It just depends on what it is.'
UPI
an hour ago
- UPI
Larger statin dosages urged for many with cholesterol, heart risks
1 of 2 | Dr. Charles Hennekens, a medical school professor and heart disease researcher at Florida Atlantic University in Boca Raton, Fla., says too many patients at high risk of heart attacks and stroke are being "underdosed" with beneficial statin drugs. Photo by Alex Dolce, Florida Atlantic University ST. PAUL, Minn., July 31 (UPI) -- Doctors are routinely "underdosing" statins for patients at risk for heart attacks and strokes due to elevated levels of "bad" cholesterol, even though the drugs have proven safe and effective, a top U.S. researcher maintains. At a time when an estimated 40% of U.S. adults have metabolic syndrome -- a combination of heart risk factors including obesity, hypertension, dyslipidemia and insulin resistance -- doctors usually don't start them off with the maximum dosage of statins, even though they can quickly lower levels of LDL cholesterol, according to an opinion published this month in the medical journal Trends in Cardiovascular Medicine. Co-author Dr. Charles Hennekens, the Sir Richard Doll Professor of Medicine and Preventive Medicine at Florida Atlantic University's Charles E. Schmidt College of Medicine in Boca Raton, says his analysis of several major clinical studies of the new generation of highly potent statins, such as rosuvastatin and atorvastatin, shows that maximal doses are safe and sorely needed, but aren't being prescribed. Those with metabolic syndrome have cardiovascular risks equivalent to those with prior heart attacks or strokes, yet many are "undertreated" by starting their statin regimens at low or moderate dosages, Hennekens told UPI. "The data indicate that over half of people who were put on a statin remain on the initial dose they're given, so even though the intent may be to titrate it up, it's not done in the majority of instances," he said. "So, you get on a low dose of statin and you stay on it." But this "flies at the face of the data" showing that statins "have the strongest and most consistent body of evidence supporting their prescription in treatment and prevention in both men and women including older adults," he said. "There's no threshold for LDL below which you don't see incremental benefits." The studies demonstrate newer statins can lower LDL, or bad cholesterol, in as quickly as a month and can provide related benefits, such as stabilizing the build-up of harmful plaque on the cells that line the interior surface of blood vessels, Hennekens said. Therefore, he urges cardiologists who initiate drug therapies for those with metabolic syndrome to start statins at maximal tolerated levels. "Everything points to getting on the highest dose of evidence-based statin," he noted. "The goal of LDL in the high-risk secondary patients is less than 50 [milligrams per deciliter], and we have a lot to do to achieve that goal because there are lots of forces in society, especially in American society, that are making that more difficult. "For example, in the United States today, in middle-age people gain 7 to 10 pounds of body weight every 10 years, so we have a society that's fatter, but only about 21% of Americans reach the daily minimum recommendation for daily physical activity, Hennekens said. "We have a nation that would benefit enormously from therapeutic lifestyle changes, but in the end, we have such high absolute risk that many are going to require adjunctive therapy." And if so, "we make a strong case that the first one you should consider is a statin, and that every other adjunctive therapy should be viewed in the context of residual risk after the statin is given with maximal doses," Hennekens added. Other experts on the use of statins to control LDL cholesterol contacted by UPI generally agreed with the premise that dosages should start at maximum levels for those at high risk of heart disease. Dr. Laurence Sperling, the Katz Professor in Preventive Cardiology at the Emory University School of Medicine in Atlanta, noted it's already on a list of guidelines developed in 2018 by an American College of Cardiology/American Heart Association joint task force. "In patients with clinical atherosclerotic cardiovascular disease, [the guidelines say] reduce LDL cholesterol with high-intensity statin therapy or maximally tolerated statin therapy," he said. "The more LDL cholesterol is reduced on statin therapy, the greater will be subsequent risk reduction." Sperling said he agreed with the recommendation to use "a maximally tolerated statin to lower LDL-C levels by 50%." Joseph Saseen, a researcher and professor of clinical pharmacy at the University of Colorado's Skaggs School of Pharmacy and Pharmaceutical Sciences in Boulder, told UPI one reason for the low-dosage prescriptions is that cardiologists overestimate the chances of possible side effects, such as muscle aches and digestive problems. "While dose-related side effects can occur, they do not justify the routine underdosing of statins in high-risk populations," Saseen said. "Clinicians too often initiate therapy at suboptimal doses, particularly in patients with elevated [cardiovascular] risk. Evidence-based guidelines recommend starting high-intensity statin therapy, especially very high-risk secondary prevention patients." Clinical data have shown, for instance, that initiating atorvastatin at as much as 80 mg. daily "is both safe and effective in reducing cardiovascular events among secondary prevention patients," Saseen said. "Similarly, rosuvastatin at 20 mg. has been shown to be a safe and effective starting dose in primary prevention patients with elevated [high-sensitivity C-reactive protein]." Also agreeing with Hennekens' conclusion is Dr. Paul Heidenreich, a practicing cardiologist, professor at the Stanford University School of Medicine and chief of medicine at the Palo Alto, Calif., Veterans Affairs clinic. "When high intensity statins are indicated, one can recommend starting with the high intensity or beginning with moderate intensity followed by up-titration," he said. He noted some cardiologists are concerned that if patients can't tolerate a high-intensity statin, they may subsequently refuse all statins, in which case it may be better to start off with a moderate dose. "However, I feel it is rare that the patient will refuse to try a lower dose," Heidenreich said. "As the authors note, titration to a higher intensity is not as frequent as it should be, with patients staying on the initial intensity. Thus, patients are likely better off starting with the recommended high-intensity statin." The clinical data also showed that the rate of intolerance with a placebo "was surprisingly high, suggesting that patients are on the lookout for any new symptom that occurs following initiation of a new medication. It is important to stress that the vast majority of patients tolerate statins medications without side effects," he said.
